| Literature DB >> 21431839 |
Suman Kundu1, Yurii S Aulchenko, Cornelia M van Duijn, A Cecile J W Janssens.
Abstract
The rapid identification of genetic markers for multifactorial diseases from genome-wide association studies is fuelling interest in investigating the predictive ability and health care utility of genetic risk models. Various measures are available for the assessment of risk prediction models, each addressing a different aspect of performance and utility. We developed PredictABEL, a package in R that covers descriptive tables, measures and figures that are used in the analysis of risk prediction studies such as measures of model fit, predictive ability and clinical utility, and risk distributions, calibration plot and the receiver operating characteristic plot. Tables and figures are saved as separate files in a user-specified format, which include publication-quality EPS and TIFF formats. All figures are available in a ready-made layout, but they can be customized to the preferences of the user. The package has been developed for the analysis of genetic risk prediction studies, but can also be used for studies that only include non-genetic risk factors. PredictABEL is freely available at the websites of GenABEL ( http://www.genabel.org ) and CRAN ( http://cran.r-project.org/).Entities:
Mesh:
Substances:
Year: 2011 PMID: 21431839 PMCID: PMC3088798 DOI: 10.1007/s10654-011-9567-4
Source DB: PubMed Journal: Eur J Epidemiol ISSN: 0393-2990 Impact factor: 8.082
Measures and plots covered in PredictABEL (version 1.1)
| Measures and plots | Description | |
|---|---|---|
| Description of the data | Frequencies Univariate odds ratios | Allele and genotype frequencies by disease status Odds ratios per allele and per genotype |
| Description of the model | Multivariate odds ratios Risk distribution Predictiveness curve | Odds ratios adjusted for all predictors in the logistic regression modela Histogram of predicted risks by disease status Cumulative percentage of individuals against predicted risks |
| Overall model performance | Nagelkerke’s R2 Brier score | Percentage of variance in the outcome explained by predictors in the logistic regression modela Average squared difference between predicted risks and observed disease status |
| Calibration | Hosmer–Lemeshow statistic Calibration plot | Average difference between observed and predicted risks across subgroups Observed and predicted risks across subgroups |
| Discrimination | Receiver operating characteristic (ROC) curve Area under the ROC curve (AUC) Discrimination box plot Integrated discrimination improvement (IDI) | Sensitivity and specificity for all possible cut-off values of predicted risks Measure of discriminative accuracy Box plot of predicted risks by disease status Comparison of mean difference in predicted risks of individuals with and without the disease between initial and updated model |
| Reclassification | Reclassification table Net reclassification improvement (NRI) | Number of individuals per risk category of the initial against the updated model by disease status Net improvement in risk classification in individuals with and without the disease. |
aThese functions can only be used when the logistic regression model is constructed using the functions in PredictABEL
Fig. 1Example graphs produced by PredictABEL. a Distributions of predicted risks in individuals with and without age-related macular degeneration (AMD); b ROC plot presenting risk models without and with genetic variants; and c Calibration plot comparing predicted risks with observed risks. Figure 1a and c present the risk model based on genetic and non-genetic risk factors
Reclassification table comparing clinical risk models without and with genetic factors
| Without genetic predictors | With genetic predictors | Reclassified | Net correctly reclassified (%) | |||
|---|---|---|---|---|---|---|
| <10% | 10–35% | >35% | Increased risk | Decreased risk | ||
| Individuals without AMD | ||||||
| <5% | 2,187 | 459 | 0 | |||
| 10–35% | 1,225 | 2,913 | 357 | 816 | 1,520 | 8.8 |
| >35% | 15 | 280 | 577 | |||
| Individuals with AMD | ||||||
| <5% | 53 | 34 | 0 | |||
| 10–35% | 93 | 919 | 326 | 360 | 170 | 9.6 |
| >35% | 1 | 76 | 485 | |||
Net reclassification improvement 18.4% (95% CI 15.8–20.9); P < 0.001
AMD age-related macular degeneration, CI confidence interval. Values are numbers unless otherwise indicated. The cut-off risk thresholds chosen are for illustration purposes only and do not reflect clinically significant categories